140 related articles for article (PubMed ID: 36302488)
1. Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics prediction.
Honorio P; Hannongbua S; Saparpakorn P
Chem Biol Interact; 2022 Dec; 368():110227. PubMed ID: 36302488
[TBL] [Abstract][Full Text] [Related]
2. Binding interaction of protoberberine alkaloids against acetylcholinesterase (AChE) using molecular dynamics simulations and QM/MM calculations.
Honorio P; Sainimnuan S; Hannongbua S; Saparpakorn P
Chem Biol Interact; 2021 Aug; 344():109523. PubMed ID: 34033838
[TBL] [Abstract][Full Text] [Related]
3. Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease.
Junaid M; Islam N; Hossain MK; Ullah MO; Halim MA
PLoS One; 2019; 14(2):e0211935. PubMed ID: 30785927
[TBL] [Abstract][Full Text] [Related]
4. Binding interactions and in silico ADME prediction of isoconessimine derivatives as potent acetylcholinesterase inhibitors.
Tue-Ngeun P; Rakitikul W; Thinkumrob N; Hannongbua S; Meelua W; Jitonnom J
J Mol Graph Model; 2024 Jun; 129():108746. PubMed ID: 38401250
[TBL] [Abstract][Full Text] [Related]
5. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations.
Zhang L; Li D; Cao F; Xiao W; Zhao L; Ding G; Wang ZZ
Comb Chem High Throughput Screen; 2018; 21(1):41-49. PubMed ID: 29173156
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease.
Brunetti L; Leuci R; Carrieri A; Catto M; Occhineri S; Vinci G; Gambacorta L; Baltrukevich H; Chaves S; Laghezza A; Altomare CD; Tortorella P; Santos MA; Loiodice F; Piemontese L
Eur J Med Chem; 2022 Jul; 237():114358. PubMed ID: 35462163
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
8. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
Pandey S; Singh BK
Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations.
Malik R; Choudhary BS; Srivastava S; Mehta P; Sharma M
J Biomol Struct Dyn; 2017 Nov; 35(15):3268-3284. PubMed ID: 27782777
[TBL] [Abstract][Full Text] [Related]
10. N-(4-Hydroxyphenyl)-3,4,5-trimethoxybenzamide derivatives as potential memory enhancers: synthesis, biological evaluation and molecular simulation studies.
Piplani P; Sharma M; Mehta P; Malik R
J Biomol Struct Dyn; 2018 May; 36(7):1867-1877. PubMed ID: 28565938
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, Molecular Docking, and Molecular Dynamics Simulation Studies of Novel 3-Hydroxypyridine-4-one Derivatives as Potential Acetylcholinesterase Inhibitors.
Asgarshamsi MH; Fassihi A; Dehkordi MM
Chem Biodivers; 2023 Jul; 20(7):e202300325. PubMed ID: 37347200
[TBL] [Abstract][Full Text] [Related]
12. Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors.
Sahin Z; Ertas M; Bender C; Bülbül EF; Berk B; Biltekin SN; Yurttaş L; Demirayak Ş
Drug Dev Res; 2018 Dec; 79(8):406-425. PubMed ID: 30343499
[TBL] [Abstract][Full Text] [Related]
13. Interaction of metal chelators with different molecular forms of acetylcholinesterase and its significance in Alzheimer's disease treatment.
Chitra L; Kumar CR; Basha HM; Ponne S; Boopathy R
Proteins; 2013 Jul; 81(7):1179-91. PubMed ID: 23408593
[TBL] [Abstract][Full Text] [Related]
14. Proposing novel natural compounds against Alzheimer's disease targeting acetylcholinesterase.
Girgin M; Isik S; Kantarci-Carsibasi N
PLoS One; 2023; 18(4):e0284994. PubMed ID: 37104478
[TBL] [Abstract][Full Text] [Related]
15. Discovery of dual cation-π inhibitors of acetylcholinesterase: design, synthesis and biological evaluation.
Damuka N; Kammari K; Potshangbam AM; Rathore RS; Kondapi AK; Vindal V
Pharmacol Rep; 2020 Jun; 72(3):705-718. PubMed ID: 32200493
[TBL] [Abstract][Full Text] [Related]
16. Phenoxyethyl Piperidine/Morpholine Derivatives as PAS and CAS Inhibitors of Cholinesterases: Insights for Future Drug Design.
Pourshojaei Y; Abiri A; Eskandari K; Haghighijoo Z; Edraki N; Asadipour A
Sci Rep; 2019 Dec; 9(1):19855. PubMed ID: 31882733
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a New Class of Spirooxindole-Benzo[
Barakat A; Alshahrani S; Al-Majid AM; Ali M; Altowyan MS; Islam MS; Alamary AS; Ashraf S; Ul-Haq Z
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066293
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-Alzheimer potential of novel α-amino phosphonate derivatives and probing their molecular interaction mechanism with acetylcholinesterase.
Yelamanda Rao K; Jeelan Basha S; Monika K; Sreelakshmi M; Sivakumar I; Mallikarjuna G; Yadav RM; Kumar S; Subramanyam R; Damu AG
Eur J Med Chem; 2023 May; 253():115288. PubMed ID: 37031527
[TBL] [Abstract][Full Text] [Related]
19. Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation.
Hasan AH; Murugesan S; Amran SI; Chander S; Alanazi MM; Hadda TB; Shakya S; Pratama MRF; Das B; Biswas S; Jamalis J
Bioorg Chem; 2022 Feb; 119():105572. PubMed ID: 34971946
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.
Deb PK; Sharma A; Piplani P; Akkinepally RR
Mol Divers; 2012 Nov; 16(4):803-23. PubMed ID: 22996404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
